Faculty Appointments
Associate Professor of Medicine
Education
M.B.B.S., B.J. Medical College, Ahmedabad, India
Office Address
2220 Pierce Ave
686 Preston research building
Nashville, TN 37232
686 Preston research building
Nashville, TN 37232
Research Description
Novel strategies to improve efficacy and safety of CAR T-cell therapy, allogeneic stem cell transplantation in lymphoid malignancies
Research Keywords
CAR T therapy, stem cell transplant, Multiple Myeloma, Lymphoma, Leukemia
Clinical Research Keywords
Adoptive cellular immunotherapy (CAR-T), Stem cell transplantation, Non-Hodgkin lymphoma, Multiple myeloma, Acute and chronic leukemia
Publications
Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik MM, Abid MB, Aljurf M, Arai Y, Bacher U, Badar T, Badawy SM, Ballen K, Battiwalla M, Beitinjaneh A, Bejanyan N, Bhatt VR, Brown VI, Martino R, Cahn JY, Castillo P, Cerny J, Chhabra S, Copelan EA, Daly A, Dholaria B, Diaz MA, Freytes CO, Grunwald MR, Hashmi S, Hildebrandt GC, Jamy O, Joseph J, Kanakry CG, Khera N, Krem MM, Kuwatsuka Y, Lazarus HM, Lekakis LJ, Liu H, Modi D, Munshi P, Mussetti A, Palmisiano N, Patel SS, Rizzieri DA, Seo S, Shah MV, Sharma A, Solh MM, Solomon SR, Ulrickson ML, Ustun C, van der Poel MWM, Verdonck LF, Wagner JL, Wang TP, Wirk B, Zeidan AM, Litzow MR, Kebriaei P, Hourigan CS, Weisdorf DJ, Saber W, Kharfan-Dabaja MA. Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood Adv [print-electronic]. 2023 Oct 10/4/2023; PMID: 37792849, PII: 498210, DOI: 10.1182/bloodadvances.2023011308, ISSN: 2473-9537.
Bahlis NJ, Costello CL, Raje NS, Levy MY, Dholaria B, Solh M, Tomasson MH, Damore MA, Jiang S, Basu C, Skoura A, Chan EM, Trudel S, Jakubowiak A, Gasparetto C, Chu MP, Dalovisio A, Sebag M, Lesokhin AM. Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med [print-electronic]. 2023 Oct; 29(10): 2570-6. PMID: 37783970, PMCID: PMC10579053, PII: 10.1038/s41591-023-02589-w, DOI: 10.1038/s41591-023-02589-w, ISSN: 1546-170X.
Kanate AS, Majhail N, DeFilipp Z, Dhakal B, Dholaria B, Hamilton B, Herrera AF, Inamoto Y, Jain T, Perales MA, Carpenter PA, Hamadani M. Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2023 Oct; 29(10): 594-7. PMID: 37422194, PII: S2666-6367(23)01386-6, DOI: 10.1016/j.jtct.2023.07.002.
Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS. Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial. Lancet Haematol [print-electronic]. 2023 Sep 9/27/2023; PMID: 37776872, PII: S2352-3026(23)00236-3, DOI: 10.1016/S2352-3026(23)00236-3, ISSN: 2352-3026.
Silbermann RW, Schmidt TM, Bal S, Dhakal B, Dholaria B, Biltibo E, Chhabra S, Giri S, Godby KN, Gowda S, Medvedova E, Cornell RF, Callander NS, Costa LJ. Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation. EJHaem. 2023 Aug; 4(3): 775-8. PMID: 37601885, PMCID: PMC10435700, PII: JHA2736, DOI: 10.1002/jha2.736, ISSN: 2688-6146.
Murthy GSG, Kim S, Estrada-Merly N, Abid MB, Aljurf M, Assal A, Badar T, Badawy SM, Ballen K, Beitinjaneh A, Cerny J, Chhabra S, DeFilipp Z, Dholaria B, Perez MAD, Farhan S, Freytes CO, Gale RP, Ganguly S, Gupta V, Grunwald MR, Hamad N, Hildebrandt GC, Inamoto Y, Jain T, Jamy O, Juckett M, Kalaycio M, Krem MM, Lazarus HM, Litzow M, Munker R, Murthy HS, Nathan S, Nishihori T, Ortí G, Patel SS, Van der Poel M, Rizzieri DA, Savani BN, Seo S, Solh M, Verdonck LF, Wirk B, Yared JA, Nakamura R, Oran B, Scott B, Saber W. Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica. 2023 Jul 7/1/2023; 108(7): 1900-8. PMID: 36779595, PMCID: PMC10316233, DOI: 10.3324/haematol.2022.281958, ISSN: 1592-8721.
Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 Jun 6/27/2023; 7(12): 2746-57. PMID: 36827681, PMCID: PMC10275699, PII: 494705, DOI: 10.1182/bloodadvances.2022009138, ISSN: 2473-9537.
Nagler A, Labopin M, Dholaria B, Blaise D, Bondarenko S, Vydra J, Choi G, Rovira M, Reményi P, Meijer E, Bulabois CE, Diez-Martin JL, Yakoub-Agha I, Brissot E, Spyridonidis A, Sanz J, Patel A, Arat M, Bazarbachi A, Bug G, Savani BN, Giebel S, Ciceri F, Mohty M. Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission. Br J Haematol [print-electronic]. 2023 Jun; 201(6): 1169-78. PMID: 36949658, DOI: 10.1111/bjh.18765, ISSN: 1365-2141.
Marvin-Peek J, Mason EF, Kishtagari A, Jayani RV, Dholaria B, Kim TK, Engelhardt BG, Chen H, Strickland S, Savani B, Ferrell B, Kassim A, Savona M, Mohan S, Byrne M. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Transplant Cell Ther [print-electronic]. 2023 Jun; 29(6): 390.e1-390.e10-390.e10. PMID: 36906277, PII: S2666-6367(23)01166-1, DOI: 10.1016/j.jtct.2023.03.008, ISSN: 2666-6367.
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, Copelan EA, Craddock C, Dholaria B, Perez MAD, Ebens CL, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Iqbal M, Jamy O, Kharfan-Dabaja MA, Khera N, Lazarus HM, Lin R, Modi D, Nathan S, Nishihori T, Patel SS, Pawarode A, Saber W, Sharma A, Solh M, Wagner JL, Wang T, Williams KM, Winestone LE, Wirk B, Zeidan A, Hourigan CS, Litzow M, Kebriaei P, de Lima M, Page K, Weisdorf DJ. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia. 2023 May; 37(5): 1173. PMID: 36949156, PII: 10.1038/s41375-023-01814-2, DOI: 10.1038/s41375-023-01814-2, ISSN: 1476-5551.
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, Copelan EA, Craddock C, Dholaria B, Perez MAD, Ebens CL, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Iqbal M, Jamy O, Kharfan-Dabaja MA, Khera N, Lazarus HM, Lin R, Modi D, Nathan S, Nishihori T, Patel SS, Pawarode A, Saber W, Sharma A, Solh M, Wagner JL, Wang T, Williams KM, Winestone LE, Wirk B, Zeidan A, Hourigan CS, Litzow M, Kebriaei P, de Lima M, Page K, Weisdorf DJ. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia [print-electronic]. 2023 May; 37(5): 1006-17. PMID: 36310182, PMCID: PMC10148918, PII: 10.1038/s41375-022-01738-3, DOI: 10.1038/s41375-022-01738-3, ISSN: 1476-5551.
Del Toro-Mijares R, Oluwole O, Jayani RV, Kassim AA, Savani BN, Dholaria B. Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options. Br J Haematol [print-electronic]. 2023 Apr; 201(1): 15-24. PMID: 36709623, DOI: 10.1111/bjh.18656, ISSN: 1365-2141.
Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. Transplant Cell Ther [print-electronic]. 2023 Mar; 29(3): 174.e1-174.e10-174.e10. PMID: 36494017, PII: S2666-6367(22)01802-4, DOI: 10.1016/j.jtct.2022.11.029, ISSN: 2666-6367.
DeFilipp Z, Ciurea SO, Cutler C, Robin M, Warlick ED, Nakamura R, Brunner AM, Dholaria B, Walker AR, Kröger N, Bejanyan N, Atallah E, Tamari R, Solh MM, Percival ME, de Lima M, Scott B, Oran B, Garcia-Manero G, Hamadani M, Carpenter P, DeZern AE. Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines. Transplant Cell Ther [print-electronic]. 2023 Feb; 29(2): 71-81. PMID: 36436780, PII: S2666-6367(22)01782-1, DOI: 10.1016/j.jtct.2022.11.014.
Zurko J, Ramdial J, Shadman M, Ahmed S, Szabo A, Iovino L, Tomas AA, Sauter C, Perales MA, Shah NN, Acharya UH, Jacobson C, Soiffer RJ, Wang T, Komanduri KV, Jaglowski S, Kittai AS, Denlinger N, Iqbal M, Kharfan-Dabaja MA, Ayala E, Chavez J, Jain M, Locke FL, Samara Y, Budde LE, Mei MG, Pia AD, Feldman T, Ahmed N, Jacobs R, Ghosh N, Dholaria B, Oluwole OO, Hess B, Hassan A, Kenkre VP, Reagan P, Awan F, Nieto Y, Hamadani M, Herrera AF. Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma. Haematologica. 2023 Jan 1/1/2023; 108(1): 98-109. PMID: 35833303, PMCID: PMC9827150, DOI: 10.3324/haematol.2022.281242, ISSN: 1592-8721.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant. 2022 Dec; 57(12): 1854. PMID: 36207624, PII: 10.1038/s41409-022-01834-z, DOI: 10.1038/s41409-022-01834-z, ISSN: 1476-5365.
Nagler A, Labopin M, Dholaria B, Ciceri F, Fraccaroli A, Blaise D, Fanin R, Bruno B, Forcade E, Vydra J, Chevallier P, Bulabois CE, Jindra P, Bornhäuser M, Canaani J, Sanz J, Savani BN, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Transplant Cell Ther [print-electronic]. 2022 Nov; 28(11): 773.e1-773.e8-773.e8. PMID: 36031079, PII: S2666-6367(22)01556-1, DOI: 10.1016/j.jtct.2022.08.018, ISSN: 2666-6367.
Riedell PA, Hwang WT, Nastoupil LJ, Pennisi M, McGuirk JP, Maziarz RT, Bachanova V, Oluwole OO, Brower J, Flores OA, Ahmed N, Schachter L, Bharucha K, Dholaria BR, Schuster SJ, Perales MA, Bishop MR, Porter DL. Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas. Transplant Cell Ther [print-electronic]. 2022 Oct; 28(10): 669-76. PMID: 35850429, PMCID: PMC9547952, PII: S2666-6367(22)01474-9, DOI: 10.1016/j.jtct.2022.07.011, ISSN: 2666-6367.
Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall A, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS. Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. J Clin Oncol [print-electronic]. 2022 Sep 9/1/2022; 40(25): 2901-12. PMID: 34898239, DOI: 10.1200/JCO.21.01935, ISSN: 1527-7755.
Dholaria B, Mehraban N, Baer B, Long N, Jayani RV, Byrne MT, Kassim AA, Engelhardt BG, Savani BN, Oluwole OO. Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience [letter]. Br J Haematol [print-electronic]. 2022 Sep; 198(6): 1073-5. PMID: 35765247, DOI: 10.1111/bjh.18339, ISSN: 1365-2141.
Bal S, Dhakal B, Silbermann RW, Schmidt TM, Dholaria B, Giri S, Chhabra S, Medvedova E, Godby KN, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS, Costa LJ. Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy. Am J Hematol [print-electronic]. 2022 Sep; 97(9): 1170-7. PMID: 35731911, DOI: 10.1002/ajh.26640, ISSN: 1096-8652.
Ahmed N, Kumar A, Kharfan-Dabaja MA, DeFilipp Z, Herrera A, Hashmi S, Dholaria B, Perales MA, Carpenter PA, Hamadani M. ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy. Transplant Cell Ther [print-electronic]. 2022 Sep; 28(9): 523-9. PMID: 35671986, PII: S2666-6367(22)01360-4, DOI: 10.1016/j.jtct.2022.05.043.
Dholaria B, Radujkovic A, Estrada-Merly N, Sirait T, Kim S, Hernández-Boluda JC, Czerw T, Hayden PJ, Kansagra A, Ho VT, Nishihori T, Shaughnessy P, Scott B, Nakamura R, Oran B, Kharfan-Dabaja M, Savani BN, McLornan D, Yakoub-Agha I, Saber W. Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis [letter]. Br J Haematol [print-electronic]. 2022 Aug; 198(4): 785-9. PMID: 35658101, PMCID: PMC9750039, DOI: 10.1111/bjh.18297, ISSN: 1365-2141.
Dholaria B, Kishtagari A, Mason EF. Oligoclonal gamma-delta T cell expansion in response to Ehrlichia infection. Am J Hematol [print-electronic]. 2022 Aug; 97(8): 1116-7. PMID: 34985779, DOI: 10.1002/ajh.26456, ISSN: 1096-8652.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant [print-electronic]. 2022 Jul; 57(7): 1116-23. PMID: 35501565, PII: 10.1038/s41409-022-01693-8, DOI: 10.1038/s41409-022-01693-8, ISSN: 1476-5365.
Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A. Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplant Cell Ther [print-electronic]. 2022 May; 28(5): 277.e1-277.e6-277.e6. PMID: 35181561, PII: S2666-6367(22)00089-6, DOI: 10.1016/j.jtct.2022.02.010, ISSN: 2666-6367.
Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther [print-electronic]. 2022 Apr; 28(4): 187.e1-187.e10-187.e10. PMID: 35081472, PMCID: PMC8977261, PII: S2666-6367(22)00036-7, DOI: 10.1016/j.jtct.2022.01.017, ISSN: 2666-6367.
Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Transplant Cell Ther [print-electronic]. 2022 Feb; 28(2): 86.e1-86.e8-86.e8. PMID: 34856420, PII: S2666-6367(21)01360-9, DOI: 10.1016/j.jtct.2021.11.013, ISSN: 2666-6367.
Marvin-Peek J, Savani BN, Olalekan OO, Dholaria B. Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia. Cancers (Basel). 2022 Jan 1/19/2022; 14(3): PMID: 35158765, PMCID: PMC8833567, PII: cancers14030497, DOI: 10.3390/cancers14030497, ISSN: 2072-6694.
Bhaskar ST, Dholaria BR, Sengsayadeth SM, Savani BN, Oluwole OO. Role of bridging therapy during chimeric antigen receptor T cell therapy. EJHaem. 2022 Jan; 3(Suppl 1): 39-45. PMID: 35844303, PMCID: PMC9175845, PII: JHA2335, DOI: 10.1002/jha2.335, ISSN: 2688-6146.
Sengsayadeth SM, Dholaria BR, Savani BN, Oluwole OO. Chimeric antigen receptor-T cell therapies: The changing landscape [editorial]. EJHaem. 2022 Jan; 3(Suppl 1): 3-5. PMID: 35844302, PMCID: PMC9176045, PII: JHA2340, DOI: 10.1002/jha2.340, ISSN: 2688-6146.
Gatwood KS, Dholaria BR, Lucena M, Baer B, Savani BN, Oluwole OO. Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration. EJHaem. 2022 Jan; 3(Suppl 1): 54-60. PMID: 35844300, PMCID: PMC9176074, PII: JHA2333, DOI: 10.1002/jha2.333, ISSN: 2688-6146.
Patel U, Abernathy J, Savani BN, Oluwole O, Sengsayadeth S, Dholaria B. CAR T cell therapy in solid tumors: A review of current clinical trials. EJHaem. 2022 Jan; 3(Suppl 1): 24-31. PMID: 35844304, PMCID: PMC9175685, PII: JHA2356, DOI: 10.1002/jha2.356, ISSN: 2688-6146.
Sengsayadeth S, Savani BN, Oluwole O, Dholaria B. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice. EJHaem. 2022 Jan; 3(Suppl 1): 6-10. PMID: 35844299, PMCID: PMC9175669, PII: JHA2338, DOI: 10.1002/jha2.338, ISSN: 2688-6146.
Patel A, Oluwole O, Savani B, Dholaria B. Taking a BiTE out of the CAR T space race. Br J Haematol [print-electronic]. 2021 Dec; 195(5): 689-97. PMID: 34131894, DOI: 10.1111/bjh.17622, ISSN: 1365-2141.
Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A. A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients [letter]. Bone Marrow Transplant [print-electronic]. 2021 Nov 11/20/2021; PMID: 34802047, PII: 10.1038/s41409-021-01527-z, DOI: 10.1038/s41409-021-01527-z, ISSN: 1476-5365.
Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther [print-electronic]. 2021 Nov 11/12/2021; PMID: 34781066, PII: S2666-6367(21)01358-0, DOI: 10.1016/j.jtct.2021.10.022, ISSN: 2666-6367.
Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021. J Natl Compr Canc Netw. 2021 Nov; 19(11): 1218-30. PMID: 34781267, PII: jnccn1911glins, DOI: 10.6004/jnccn.2021.0054, ISSN: 1540-1413.
Abedin S, Rashid N, Schroeder M, Romee R, Nauffal M, Alhaj Moustafa M, Kharfan-Dabaja MA, Palmer J, Hogan W, Hefazi M, Larson S, Holtan S, DeFilipp Z, Jayani R, Dholaria B, Pidala J, Khimani F, Grunwald MR, Butler C, Hamadani M. Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis. Br J Haematol [print-electronic]. 2021 Nov; 195(3): 429-32. PMID: 34254289, DOI: 10.1111/bjh.17700, ISSN: 1365-2141.
Kunte S, Rybicki L, Viswabandya A, Tamari R, Bashey A, Keyzner A, Iqbal M, Grunwald MR, Dholaria B, Elmariah H, Ozga M, Singh A, Abedin S, DeZern AE, Jones RJ, Gupta V, Gerds AT, Jain T. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. Leukemia [print-electronic]. 2021 Oct 10/18/2021; PMID: 34663912, PII: 10.1038/s41375-021-01449-1, DOI: 10.1038/s41375-021-01449-1, ISSN: 1476-5551.
Savani M, Oluwole O, Dholaria B. New targets for CAR T therapy in hematologic malignancies. Best Pract Res Clin Haematol [print-electronic]. 2021 Sep; 34(3): 101277. PMID: 34625226, PII: S1521-6926(21)00042-6, DOI: 10.1016/j.beha.2021.101277, ISSN: 1532-1924.
Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Aug; 27(8): 642-9. PMID: 34304802, PII: S2666-6367(21)00831-9, DOI: 10.1016/j.jtct.2021.04.007.
Geethakumari PR, Ramasamy DP, Dholaria B, Berdeja J, Kansagra A. Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments. Curr Hematol Malig Rep [print-electronic]. 2021 Aug; 16(4): 345-56. PMID: 34089485, PMCID: PMC8179081, PII: 10.1007/s11899-021-00635-3, DOI: 10.1007/s11899-021-00635-3, ISSN: 1558-822X.
Scordo M, Wang TP, Ahn KW, Chen Y, Ahmed S, Awan FT, Beitinjaneh A, Chen A, Chow VA, Dholaria B, Epperla N, Farooq U, Ghosh N, Grover N, Hamad N, Hildebrandt GC, Holmberg L, Hong S, Inwards DJ, Jimenez-Jimenez A, Karmali R, Kenkre VP, Khimani F, Klyuchnikov E, Krem MM, Munshi PN, Nieto Y, Prestidge T, Ramakrishnan Geethakumari P, Rezvani AR, Riedell PA, Seo S, Shah NN, Solh M, Yared JA, Kharfan-Dabaja MA, Herrera A, Hamadani M, Sauter CS. Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant. JAMA Oncol. 2021 Jul 7/1/2021; 7(7): 993-1003. PMID: 33956047, PMCID: PMC8283558, PII: 2779525, DOI: 10.1001/jamaoncol.2021.1074, ISSN: 2374-2445.
Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D. Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia [print-electronic]. 2021 Jul; 35(7): 2076-85. PMID: 33785862, PMCID: PMC8257494, PII: 10.1038/s41375-021-01213-5, DOI: 10.1038/s41375-021-01213-5, ISSN: 1476-5551.
Dholaria B, Savani BN, Huang XJ, Nagler A, Perales MA, Mohty M. The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy. Br J Haematol [print-electronic]. 2021 Jun; 193(6): 1060-75. PMID: 33928630, DOI: 10.1111/bjh.17460, ISSN: 1365-2141.
Dholaria B, Labopin M, Sanz J, Ruggeri A, Cornelissen J, Labussière-Wallet H, Blaise D, Forcade E, Chevallier P, Grassi A, Zubarovskaya L, Kuball J, Ceballos P, Ciceri F, Baron F, Savani BN, Nagler A, Mohty M. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia. J Hematol Oncol. 2021 May 5/3/2021; 14(1): 76. PMID: 33941226, PMCID: PMC8094558, PII: 10.1186/s13045-021-01086-2, DOI: 10.1186/s13045-021-01086-2, ISSN: 1756-8722.
Logue JM, Zucchetti E, Bachmeier CA, Krivenko GS, Larson V, Ninh D, Grillo G, Cao B, Kim J, Chavez JC, Baluch A, Khimani F, Lazaryan A, Nishihori T, Liu HD, Pinilla-Ibarz J, Shah BD, Faramand R, Coghill AE, Davila ML, Dholaria BR, Jain MD, Locke FL. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2021 Apr 4/1/2021; 106(4): 978-86. PMID: 32327504, PMCID: PMC8017820, PII: haematol.2019.238634, DOI: 10.3324/haematol.2019.238634, ISSN: 1592-8721.
Dholaria B, Labopin M, Angelucci E, Tischer J, Arat M, Ciceri F, Gülbas Z, Ozdogu H, Sica S, Diez-Martin JL, Koc Y, Pavlu J, Socié G, Giebel S, Savani BN, Nagler A, Mohty M. Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. Transplant Cell Ther [print-electronic]. 2021 Feb; 27(2): 171.e1-171.e8. PMID: 33830029, PII: S2666-6367(20)30017-8, DOI: 10.1016/j.jtct.2020.10.008, ISSN: 2666-6367.
Nagler A, Labopin M, Dholaria B, Angelucci E, Afanasyev B, Cornelissen JJ, Sica S, Meijer E, Ciceri F, Van Gorkom G, Kröger N, Martin H, Pioltelli P, Risitano A, Canaani J, Savani BN, Sanz J, Mohty M. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clin Cancer Res [print-electronic]. 2021 Feb 2/1/2021; 27(3): 843-51. PMID: 33148668, PII: 1078-0432.CCR-20-2809, DOI: 10.1158/1078-0432.CCR-20-2809, ISSN: 1557-3265.
Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, Ciurea SO, Holtzman NG, Ii GLP, Devine SM, Mannis G, Grunwald MR, Appelbaum F, Rodriguez C, El Chaer F, Shah N, Hashmi SK, Kharfan-Dabaja MA, DeFilipp Z, Aljurf M, AlShaibani A, Inamoto Y, Jain T, Majhail N, Perales MA, Mohty M, Hamadani M, Carpenter PA, Nagler A. Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2021 Jan; 27(1): 6-20. PMID: 32966881, PII: S1083-8791(20)30584-X, DOI: 10.1016/j.bbmt.2020.09.020.
Nagler A, Dholaria B, Labopin M, Bruno B, Rambaldi A, Pioltelli P, La Nasa G, Socié G, Mielke S, Ruggeri M, Saccardi R, Franke GN, Finke J, Savani BN, Ruggeri A, Mohty M. The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. Bone Marrow Transplant [print-electronic]. 2021 Jan; 56(1): 20-9. PMID: 32561816, PII: 10.1038/s41409-020-0974-6, DOI: 10.1038/s41409-020-0974-6, ISSN: 1476-5365.
Gorsline CA, Staub MB, Nelson GE, Nesbitt WJ, Dholaria BR, Satyanarayana G. Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers. Antimicrob Steward Healthc Epidemiol. 2021; 1(1): e22. PMID: 36168451, PMCID: PMC9495534, PII: S2732494X21001856, DOI: 10.1017/ash.2021.185, ISSN: 2732-494X.
Mangan BL, Patel D, Chen H, Gatwood KS, Byrne MT, Sengsayadeth S, Goodman S, Dholaria B, Kassim AA, Jagasia M, Chinratanalab W, Culos KA, Engelhardt BG. New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide. EJHaem [print-electronic]. 2020 Nov; 1(2): 576-80. PMID: 33709085, PMCID: PMC7942195, DOI: 10.1002/jha2.70, ISSN: 2688-6146.
Bar M, Ott SM, Lewiecki EM, Sarafoglou K, Wu JY, Thompson MJ, Vaux JJ, Dean DR, Saag KG, Hashmi SK, Inamoto Y, Dholaria BR, Kharfan-Dabaja MA, Nagler A, Rodriguez C, Hamilton BK, Shah N, Flowers MED, Savani BN, Carpenter PA. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant [print-electronic]. 2020 Oct; 26(10): 1784-802. PMID: 32653624, PII: S1083-8791(20)30410-9, DOI: 10.1016/j.bbmt.2020.07.001.
Patel A, Mobley BC, Jagasia M, Adetola K, Byrne M, Dholaria B. Pituitary Apoplexy During Hematopoietic Cell Transplantation. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Oct; 20(10): e691-e693. PMID: 32620383, PII: S2152-2650(20)30261-5, DOI: 10.1016/j.clml.2020.05.015, ISSN: 2152-2669.
Nagler A, Dholaria B, Labopin M, Savani BN, Angelucci E, Koc Y, Arat M, Pioltelli P, Sica S, Gülbas Z, Tischer J, Bernasconi P, Pavlu J, Socié G, Blaise D, Rigacci L, Martino M, Diez-Martin JL, Peric Z, Giebel S, Mohty M. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia [print-electronic]. 2020 Oct; 34(10): 2766-75. PMID: 32393841, PII: 10.1038/s41375-020-0850-9, DOI: 10.1038/s41375-020-0850-9, ISSN: 1476-5551.
Byrne M, Danielson N, Sengsayadeth S, Rasche A, Culos K, Gatwood K, Wyatt H, Chinratanalab W, Dholaria B, Ferrell PB, Fogo K, Goodman S, Jagasia M, Jayani R, Kassim A, Mohan SR, Savani BN, Strickland SA, Engelhardt BG, Savona M. The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. Am J Hematol [print-electronic]. 2020 Sep; 95(9): 1006-14. PMID: 32390196, DOI: 10.1002/ajh.25859, ISSN: 1096-8652.
Dholaria B, Vanegas YAM, Diehl N, Spaulding AC, Visscher S, Tun HW, Ailawadhi S, Vishnu P. Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features. Clin Hematol Int. 2020 Sep; 2(3): 117-24. PMID: 34595452, PMCID: PMC8432333, PII: CHI-2-3-117, DOI: 10.2991/chi.d.200410.001, ISSN: 2590-0048.
Dholaria B, Labopin M, Angelucci E, Ciceri F, Diez-Martin JL, Bruno B, Sica S, Koc Y, Gülbas Z, Schmid C, Blaise D, Carella AM, Visani G, Savani BN, Nagler A, Mohty M. Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia. Am J Hematol [print-electronic]. 2020 Jul 7/13/2020; PMID: 32656791, DOI: 10.1002/ajh.25934, ISSN: 1096-8652.
Dholaria B, Malki MMA, Artz A, Savani BN. Securing the graft during pandemic: are we ready for cryopreservation for all?. Biol Blood Marrow Transplant [print-electronic]. 2020 Jul; 26(7): e145-e146. PMID: 32305358, PMCID: PMC7162777, PII: S1083-8791(20)30219-6, DOI: 10.1016/j.bbmt.2020.04.009, ISSN: 1523-6536.
Bachanova V, Bishop MR, Dahi P, Dholaria B, Grupp SA, Hayes-Lattin B, Janakiram M, Maziarz RT, McGuirk JP, Nastoupil LJ, Oluwole OO, Perales MA, Porter DL, Riedell PA, . Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant [print-electronic]. 2020 Jul; 26(7): 1239-46. PMID: 32298807, PMCID: PMC7194685, PII: S1083-8791(20)30217-2, DOI: 10.1016/j.bbmt.2020.04.008, ISSN: 1523-6536.
Dholaria B, Savani BN. How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?. Br J Haematol [print-electronic]. 2020 Apr; 189(2): 239-40. PMID: 32180224, PMCID: PMC7161755, DOI: 10.1111/bjh.16597, ISSN: 1365-2141.
Moreno Vanegas YA, Juskevicius R, Dholaria B. Hepatitis C Virus-associated Lymphoplasmacytic Lymphoma With Waldenström Macroglobulinemia: Response to Direct-acting Antiviral Therapy. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Apr; 20(4): e195-e199. PMID: 32033929, PII: S2152-2650(20)30040-9, DOI: 10.1016/j.clml.2020.01.004, ISSN: 2152-2669.
Nagler A, Dholaria B, Labopin M, Socie G, Huynh A, Itälä-Remes M, Deconinck E, Yakoub-Agha I, Cahn JY, Bourhis JH, Labussière-Wallet H, Chantepie S, Esteve J, Savani B, Mohty M. The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation. Leukemia [print-electronic]. 2019 Nov 11/14/2019; PMID: 31728052, PII: 10.1038/s41375-019-0631-5, DOI: 10.1038/s41375-019-0631-5, ISSN: 1476-5551.
Dholaria B, Savani BN. Allogeneic haematopoietic cell transplantation after CAR T-cell therapy: safe, effective and contentious [editorial]. Br. J. Haematol [print-electronic]. 2019 Nov 11/8/2019; PMID: 31702832, DOI: 10.1111/bjh.16262, ISSN: 1365-2141.
Hammond WA, Vishnu P, Rodriguez EM, Li Z, Dholaria B, Shreders AJ, Rivera CE. Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?. Mayo Clin. Proc. 2019 Nov; 94(11): 2199-208. PMID: 31685150, PII: S0025-6196(19)30506-3, DOI: 10.1016/j.mayocp.2019.05.024, ISSN: 1942-5546.
Dholaria B, Savani BN, Labopin M, Luznik L, Ruggeri A, Mielke S, Al Malki MM, Kongtim P, Fuchs E, Huang XJ, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Solomon S, Romee R, Lewalle P, Gayoso J, Maschan M, Lazarus HM, Ballen K, Giebel S, Baron F, Ciceri F, Esteve J, Gorin NC, Spyridonidis A, Schmid C, Ciurea SO, Nagler A, Mohty M. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT. Haematologica [print-electronic]. 2019 Sep 9/19/2019; PMID: 31537691, PII: haematol.2019.219790, DOI: 10.3324/haematol.2019.219790, ISSN: 1592-8721.
Nagler A, Labopin M, Dholaria B, Niittyvuopio R, Maertens J, Poiré X, Cornelissen J, Reményi P, Bourhis JH, Beguin Y, Malladi R, Kerre T, Schroyens W, Savani BN, Mohty M. Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Adv. 2019 Jul 7/9/2019; 3(13): 1950-60. PMID: 31262738, PMCID: PMC6616257, PII: bloodadvances.2019000030, DOI: 10.1182/bloodadvances.2019000030, ISSN: 2473-9537.
Soyano AE, Dholaria B, Marin-Acevedo JA, Diehl N, Hodge D, Luo Y, Manochakian R, Chumsri S, Adjei A, Knutson KL, Lou Y. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies. J Immunother Cancer. 2018 Nov 11/23/2018; 6(1): 129. PMID: 30470260, PMCID: PMC6251165, PII: 10.1186/s40425-018-0447-2, DOI: 10.1186/s40425-018-0447-2, ISSN: 2051-1426.
Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S. Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med [print-electronic]. 2018 Oct; 7(10): 4932-42. PMID: 30175515, PMCID: PMC6198232, DOI: 10.1002/cam4.1749, ISSN: 2045-7634.
Ailawadhi S, Dholaria BR, Khurana S, Sher T, Alegria V, Paulus A, Ailawadhi M, Mehta A, Chanan-Khan A, Roy V. Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma [letter]. Br. J. Haematol [print-electronic]. 2018 Jul 7/5/2018; PMID: 29978498, DOI: 10.1111/bjh.15458, ISSN: 1365-2141.
Dholaria BR, Ayala E, Sokol L, Nishihori T, Chavez JC, Hussaini M, Kumar A, Kharfan-Dabaja MA. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience. Leuk. Res [print-electronic]. 2018 Apr; 67: 1-5. PMID: 29407180, PII: S0145-2126(18)30015-8, DOI: 10.1016/j.leukres.2018.01.009, ISSN: 1873-5835.
Dholaria BR, Hammond WA, Roy V, Sher T, Vishnu P, Soyano A, Finn LE, Tun H. Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience. Leuk. Lymphoma [print-electronic]. 2018 Mar 3/23/2018; 1-4. PMID: 29566563, DOI: 10.1080/10428194.2018.1452220, ISSN: 1029-2403.
Marin-Acevedo JA, Dholaria B, Soyano AE, Knutson KL, Chumsri S, Lou Y. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 3/15/2018; 11(1): 39. PMID: 29544515, PMCID: PMC5856308, PII: 10.1186/s13045-018-0582-8, DOI: 10.1186/s13045-018-0582-8, ISSN: 1756-8722.
Marin-Acevedo JA, Soyano AE, Dholaria B, Knutson KL, Lou Y. Cancer immunotherapy beyond immune checkpoint inhibitors. J Hematol Oncol. 2018 Jan 1/12/2018; 11(1): 8. PMID: 29329556, PMCID: PMC5767051, PII: 10.1186/s13045-017-0552-6, DOI: 10.1186/s13045-017-0552-6, ISSN: 1756-8722.
Dholaria B, Patel RJ, Sluzevich JC, Ailawadhi S, Roy V. Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant. Ann. Hematol [print-electronic]. 2017 Dec; 96(12): 2125-6. PMID: 28879427, PII: 10.1007/s00277-017-3119-2, DOI: 10.1007/s00277-017-3119-2, ISSN: 1432-0584.
Dholaria B, Hammond W, Shreders A, Lou Y. Emerging therapeutic agents for lung cancer. J Hematol Oncol. 2016 Dec 12/9/2016; 9(1): 138. PMID: 27938382, PMCID: PMC5148871, PII: 10.1186/s13045-016-0365-z, DOI: 10.1186/s13045-016-0365-z, ISSN: 1756-8722.
Dholaria B, Bhasin A, Krishna M, Finn L. Adoptive transfer of food allergy via unrelated allogeneic bone marrow transplant. Ann. Allergy Asthma Immunol [print-electronic]. 2016 Jul; 117(1): 96-7. PMID: 27236219, PII: S1081-1206(16)30184-3, DOI: 10.1016/j.anai.2016.04.026, ISSN: 1534-4436.
Dholaria BR, Cappel M, Roy V. Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone. Ann. Hematol [print-electronic]. 2016 Mar; 95(4): 671-2. PMID: 26814914, PII: 10.1007/s00277-016-2604-3, DOI: 10.1007/s00277-016-2604-3, ISSN: 1432-0584.
Dholaria B, Srinivasan S. T-DM1-related carotenoderma and hand-foot syndrome. Lancet. 2015 Apr 4/18/2015; 385(9977): 1509-10. PMID: 25933279, PII: S0140-6736(15)60752-8, DOI: 10.1016/S0140-6736(15)60752-8, ISSN: 1474-547X.
Dholaria BR, Pant S, Lavender RC, Agarwal A. The great imitator: psychosis that responded to penicillin. Can Fam Physician. 2014 Sep; 60(9): 818-21. PMID: 25217678, PMCID: PMC4162698, PII: 60/9/818, ISSN: 1715-5258.
Dholaria B, Alapat D, Arnaoutakis K. Primary bone marrow Hodgkin lymphoma in an HIV-negative patient. Int. J. Hematol [print-electronic]. 2014 Apr; 99(4): 503-7. PMID: 24532438, DOI: 10.1007/s12185-014-1532-z, ISSN: 1865-3774.
Dholaria B, Alapat D, Pandey T, Agarwal A. Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat. Med. Oncol [print-electronic]. 2012 Dec; 29(5): 3529-34. PMID: 22562157, DOI: 10.1007/s12032-012-0248-2, ISSN: 1559-131X.
Pant S, Deshmukh A, Dholaria B, Kaur V, Ramavaram S, Ukor M, Teran GA. Spicy seizure. Am. J. Med. Sci. 2012 Jul; 344(1): 67-8. PMID: 22627260, PII: S0002-9629(15)30924-1, DOI: 10.1097/MAJ.0b013e31824cf5c2, ISSN: 1538-2990.
Bahlis NJ, Costello CL, Raje NS, Levy MY, Dholaria B, Solh M, Tomasson MH, Damore MA, Jiang S, Basu C, Skoura A, Chan EM, Trudel S, Jakubowiak A, Gasparetto C, Chu MP, Dalovisio A, Sebag M, Lesokhin AM. Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med [print-electronic]. 2023 Oct; 29(10): 2570-6. PMID: 37783970, PMCID: PMC10579053, PII: 10.1038/s41591-023-02589-w, DOI: 10.1038/s41591-023-02589-w, ISSN: 1546-170X.
Kanate AS, Majhail N, DeFilipp Z, Dhakal B, Dholaria B, Hamilton B, Herrera AF, Inamoto Y, Jain T, Perales MA, Carpenter PA, Hamadani M. Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2023 Oct; 29(10): 594-7. PMID: 37422194, PII: S2666-6367(23)01386-6, DOI: 10.1016/j.jtct.2023.07.002.
Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS. Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial. Lancet Haematol [print-electronic]. 2023 Sep 9/27/2023; PMID: 37776872, PII: S2352-3026(23)00236-3, DOI: 10.1016/S2352-3026(23)00236-3, ISSN: 2352-3026.
Silbermann RW, Schmidt TM, Bal S, Dhakal B, Dholaria B, Biltibo E, Chhabra S, Giri S, Godby KN, Gowda S, Medvedova E, Cornell RF, Callander NS, Costa LJ. Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation. EJHaem. 2023 Aug; 4(3): 775-8. PMID: 37601885, PMCID: PMC10435700, PII: JHA2736, DOI: 10.1002/jha2.736, ISSN: 2688-6146.
Murthy GSG, Kim S, Estrada-Merly N, Abid MB, Aljurf M, Assal A, Badar T, Badawy SM, Ballen K, Beitinjaneh A, Cerny J, Chhabra S, DeFilipp Z, Dholaria B, Perez MAD, Farhan S, Freytes CO, Gale RP, Ganguly S, Gupta V, Grunwald MR, Hamad N, Hildebrandt GC, Inamoto Y, Jain T, Jamy O, Juckett M, Kalaycio M, Krem MM, Lazarus HM, Litzow M, Munker R, Murthy HS, Nathan S, Nishihori T, Ortí G, Patel SS, Van der Poel M, Rizzieri DA, Savani BN, Seo S, Solh M, Verdonck LF, Wirk B, Yared JA, Nakamura R, Oran B, Scott B, Saber W. Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica. 2023 Jul 7/1/2023; 108(7): 1900-8. PMID: 36779595, PMCID: PMC10316233, DOI: 10.3324/haematol.2022.281958, ISSN: 1592-8721.
Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 Jun 6/27/2023; 7(12): 2746-57. PMID: 36827681, PMCID: PMC10275699, PII: 494705, DOI: 10.1182/bloodadvances.2022009138, ISSN: 2473-9537.
Nagler A, Labopin M, Dholaria B, Blaise D, Bondarenko S, Vydra J, Choi G, Rovira M, Reményi P, Meijer E, Bulabois CE, Diez-Martin JL, Yakoub-Agha I, Brissot E, Spyridonidis A, Sanz J, Patel A, Arat M, Bazarbachi A, Bug G, Savani BN, Giebel S, Ciceri F, Mohty M. Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission. Br J Haematol [print-electronic]. 2023 Jun; 201(6): 1169-78. PMID: 36949658, DOI: 10.1111/bjh.18765, ISSN: 1365-2141.
Marvin-Peek J, Mason EF, Kishtagari A, Jayani RV, Dholaria B, Kim TK, Engelhardt BG, Chen H, Strickland S, Savani B, Ferrell B, Kassim A, Savona M, Mohan S, Byrne M. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Transplant Cell Ther [print-electronic]. 2023 Jun; 29(6): 390.e1-390.e10-390.e10. PMID: 36906277, PII: S2666-6367(23)01166-1, DOI: 10.1016/j.jtct.2023.03.008, ISSN: 2666-6367.
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, Copelan EA, Craddock C, Dholaria B, Perez MAD, Ebens CL, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Iqbal M, Jamy O, Kharfan-Dabaja MA, Khera N, Lazarus HM, Lin R, Modi D, Nathan S, Nishihori T, Patel SS, Pawarode A, Saber W, Sharma A, Solh M, Wagner JL, Wang T, Williams KM, Winestone LE, Wirk B, Zeidan A, Hourigan CS, Litzow M, Kebriaei P, de Lima M, Page K, Weisdorf DJ. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia. 2023 May; 37(5): 1173. PMID: 36949156, PII: 10.1038/s41375-023-01814-2, DOI: 10.1038/s41375-023-01814-2, ISSN: 1476-5551.
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, Copelan EA, Craddock C, Dholaria B, Perez MAD, Ebens CL, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Iqbal M, Jamy O, Kharfan-Dabaja MA, Khera N, Lazarus HM, Lin R, Modi D, Nathan S, Nishihori T, Patel SS, Pawarode A, Saber W, Sharma A, Solh M, Wagner JL, Wang T, Williams KM, Winestone LE, Wirk B, Zeidan A, Hourigan CS, Litzow M, Kebriaei P, de Lima M, Page K, Weisdorf DJ. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia [print-electronic]. 2023 May; 37(5): 1006-17. PMID: 36310182, PMCID: PMC10148918, PII: 10.1038/s41375-022-01738-3, DOI: 10.1038/s41375-022-01738-3, ISSN: 1476-5551.
Del Toro-Mijares R, Oluwole O, Jayani RV, Kassim AA, Savani BN, Dholaria B. Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options. Br J Haematol [print-electronic]. 2023 Apr; 201(1): 15-24. PMID: 36709623, DOI: 10.1111/bjh.18656, ISSN: 1365-2141.
Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. Transplant Cell Ther [print-electronic]. 2023 Mar; 29(3): 174.e1-174.e10-174.e10. PMID: 36494017, PII: S2666-6367(22)01802-4, DOI: 10.1016/j.jtct.2022.11.029, ISSN: 2666-6367.
DeFilipp Z, Ciurea SO, Cutler C, Robin M, Warlick ED, Nakamura R, Brunner AM, Dholaria B, Walker AR, Kröger N, Bejanyan N, Atallah E, Tamari R, Solh MM, Percival ME, de Lima M, Scott B, Oran B, Garcia-Manero G, Hamadani M, Carpenter P, DeZern AE. Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines. Transplant Cell Ther [print-electronic]. 2023 Feb; 29(2): 71-81. PMID: 36436780, PII: S2666-6367(22)01782-1, DOI: 10.1016/j.jtct.2022.11.014.
Zurko J, Ramdial J, Shadman M, Ahmed S, Szabo A, Iovino L, Tomas AA, Sauter C, Perales MA, Shah NN, Acharya UH, Jacobson C, Soiffer RJ, Wang T, Komanduri KV, Jaglowski S, Kittai AS, Denlinger N, Iqbal M, Kharfan-Dabaja MA, Ayala E, Chavez J, Jain M, Locke FL, Samara Y, Budde LE, Mei MG, Pia AD, Feldman T, Ahmed N, Jacobs R, Ghosh N, Dholaria B, Oluwole OO, Hess B, Hassan A, Kenkre VP, Reagan P, Awan F, Nieto Y, Hamadani M, Herrera AF. Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma. Haematologica. 2023 Jan 1/1/2023; 108(1): 98-109. PMID: 35833303, PMCID: PMC9827150, DOI: 10.3324/haematol.2022.281242, ISSN: 1592-8721.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant. 2022 Dec; 57(12): 1854. PMID: 36207624, PII: 10.1038/s41409-022-01834-z, DOI: 10.1038/s41409-022-01834-z, ISSN: 1476-5365.
Nagler A, Labopin M, Dholaria B, Ciceri F, Fraccaroli A, Blaise D, Fanin R, Bruno B, Forcade E, Vydra J, Chevallier P, Bulabois CE, Jindra P, Bornhäuser M, Canaani J, Sanz J, Savani BN, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia. Transplant Cell Ther [print-electronic]. 2022 Nov; 28(11): 773.e1-773.e8-773.e8. PMID: 36031079, PII: S2666-6367(22)01556-1, DOI: 10.1016/j.jtct.2022.08.018, ISSN: 2666-6367.
Riedell PA, Hwang WT, Nastoupil LJ, Pennisi M, McGuirk JP, Maziarz RT, Bachanova V, Oluwole OO, Brower J, Flores OA, Ahmed N, Schachter L, Bharucha K, Dholaria BR, Schuster SJ, Perales MA, Bishop MR, Porter DL. Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas. Transplant Cell Ther [print-electronic]. 2022 Oct; 28(10): 669-76. PMID: 35850429, PMCID: PMC9547952, PII: S2666-6367(22)01474-9, DOI: 10.1016/j.jtct.2022.07.011, ISSN: 2666-6367.
Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall A, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS. Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. J Clin Oncol [print-electronic]. 2022 Sep 9/1/2022; 40(25): 2901-12. PMID: 34898239, DOI: 10.1200/JCO.21.01935, ISSN: 1527-7755.
Dholaria B, Mehraban N, Baer B, Long N, Jayani RV, Byrne MT, Kassim AA, Engelhardt BG, Savani BN, Oluwole OO. Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience [letter]. Br J Haematol [print-electronic]. 2022 Sep; 198(6): 1073-5. PMID: 35765247, DOI: 10.1111/bjh.18339, ISSN: 1365-2141.
Bal S, Dhakal B, Silbermann RW, Schmidt TM, Dholaria B, Giri S, Chhabra S, Medvedova E, Godby KN, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS, Costa LJ. Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy. Am J Hematol [print-electronic]. 2022 Sep; 97(9): 1170-7. PMID: 35731911, DOI: 10.1002/ajh.26640, ISSN: 1096-8652.
Ahmed N, Kumar A, Kharfan-Dabaja MA, DeFilipp Z, Herrera A, Hashmi S, Dholaria B, Perales MA, Carpenter PA, Hamadani M. ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy. Transplant Cell Ther [print-electronic]. 2022 Sep; 28(9): 523-9. PMID: 35671986, PII: S2666-6367(22)01360-4, DOI: 10.1016/j.jtct.2022.05.043.
Dholaria B, Radujkovic A, Estrada-Merly N, Sirait T, Kim S, Hernández-Boluda JC, Czerw T, Hayden PJ, Kansagra A, Ho VT, Nishihori T, Shaughnessy P, Scott B, Nakamura R, Oran B, Kharfan-Dabaja M, Savani BN, McLornan D, Yakoub-Agha I, Saber W. Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis [letter]. Br J Haematol [print-electronic]. 2022 Aug; 198(4): 785-9. PMID: 35658101, PMCID: PMC9750039, DOI: 10.1111/bjh.18297, ISSN: 1365-2141.
Dholaria B, Kishtagari A, Mason EF. Oligoclonal gamma-delta T cell expansion in response to Ehrlichia infection. Am J Hematol [print-electronic]. 2022 Aug; 97(8): 1116-7. PMID: 34985779, DOI: 10.1002/ajh.26456, ISSN: 1096-8652.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia. Bone Marrow Transplant [print-electronic]. 2022 Jul; 57(7): 1116-23. PMID: 35501565, PII: 10.1038/s41409-022-01693-8, DOI: 10.1038/s41409-022-01693-8, ISSN: 1476-5365.
Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A. Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplant Cell Ther [print-electronic]. 2022 May; 28(5): 277.e1-277.e6-277.e6. PMID: 35181561, PII: S2666-6367(22)00089-6, DOI: 10.1016/j.jtct.2022.02.010, ISSN: 2666-6367.
Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther [print-electronic]. 2022 Apr; 28(4): 187.e1-187.e10-187.e10. PMID: 35081472, PMCID: PMC8977261, PII: S2666-6367(22)00036-7, DOI: 10.1016/j.jtct.2022.01.017, ISSN: 2666-6367.
Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M. Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Transplant Cell Ther [print-electronic]. 2022 Feb; 28(2): 86.e1-86.e8-86.e8. PMID: 34856420, PII: S2666-6367(21)01360-9, DOI: 10.1016/j.jtct.2021.11.013, ISSN: 2666-6367.
Marvin-Peek J, Savani BN, Olalekan OO, Dholaria B. Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia. Cancers (Basel). 2022 Jan 1/19/2022; 14(3): PMID: 35158765, PMCID: PMC8833567, PII: cancers14030497, DOI: 10.3390/cancers14030497, ISSN: 2072-6694.
Bhaskar ST, Dholaria BR, Sengsayadeth SM, Savani BN, Oluwole OO. Role of bridging therapy during chimeric antigen receptor T cell therapy. EJHaem. 2022 Jan; 3(Suppl 1): 39-45. PMID: 35844303, PMCID: PMC9175845, PII: JHA2335, DOI: 10.1002/jha2.335, ISSN: 2688-6146.
Sengsayadeth SM, Dholaria BR, Savani BN, Oluwole OO. Chimeric antigen receptor-T cell therapies: The changing landscape [editorial]. EJHaem. 2022 Jan; 3(Suppl 1): 3-5. PMID: 35844302, PMCID: PMC9176045, PII: JHA2340, DOI: 10.1002/jha2.340, ISSN: 2688-6146.
Gatwood KS, Dholaria BR, Lucena M, Baer B, Savani BN, Oluwole OO. Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration. EJHaem. 2022 Jan; 3(Suppl 1): 54-60. PMID: 35844300, PMCID: PMC9176074, PII: JHA2333, DOI: 10.1002/jha2.333, ISSN: 2688-6146.
Patel U, Abernathy J, Savani BN, Oluwole O, Sengsayadeth S, Dholaria B. CAR T cell therapy in solid tumors: A review of current clinical trials. EJHaem. 2022 Jan; 3(Suppl 1): 24-31. PMID: 35844304, PMCID: PMC9175685, PII: JHA2356, DOI: 10.1002/jha2.356, ISSN: 2688-6146.
Sengsayadeth S, Savani BN, Oluwole O, Dholaria B. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice. EJHaem. 2022 Jan; 3(Suppl 1): 6-10. PMID: 35844299, PMCID: PMC9175669, PII: JHA2338, DOI: 10.1002/jha2.338, ISSN: 2688-6146.
Patel A, Oluwole O, Savani B, Dholaria B. Taking a BiTE out of the CAR T space race. Br J Haematol [print-electronic]. 2021 Dec; 195(5): 689-97. PMID: 34131894, DOI: 10.1111/bjh.17622, ISSN: 1365-2141.
Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A. A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients [letter]. Bone Marrow Transplant [print-electronic]. 2021 Nov 11/20/2021; PMID: 34802047, PII: 10.1038/s41409-021-01527-z, DOI: 10.1038/s41409-021-01527-z, ISSN: 1476-5365.
Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther [print-electronic]. 2021 Nov 11/12/2021; PMID: 34781066, PII: S2666-6367(21)01358-0, DOI: 10.1016/j.jtct.2021.10.022, ISSN: 2666-6367.
Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021. J Natl Compr Canc Netw. 2021 Nov; 19(11): 1218-30. PMID: 34781267, PII: jnccn1911glins, DOI: 10.6004/jnccn.2021.0054, ISSN: 1540-1413.
Abedin S, Rashid N, Schroeder M, Romee R, Nauffal M, Alhaj Moustafa M, Kharfan-Dabaja MA, Palmer J, Hogan W, Hefazi M, Larson S, Holtan S, DeFilipp Z, Jayani R, Dholaria B, Pidala J, Khimani F, Grunwald MR, Butler C, Hamadani M. Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis. Br J Haematol [print-electronic]. 2021 Nov; 195(3): 429-32. PMID: 34254289, DOI: 10.1111/bjh.17700, ISSN: 1365-2141.
Kunte S, Rybicki L, Viswabandya A, Tamari R, Bashey A, Keyzner A, Iqbal M, Grunwald MR, Dholaria B, Elmariah H, Ozga M, Singh A, Abedin S, DeZern AE, Jones RJ, Gupta V, Gerds AT, Jain T. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. Leukemia [print-electronic]. 2021 Oct 10/18/2021; PMID: 34663912, PII: 10.1038/s41375-021-01449-1, DOI: 10.1038/s41375-021-01449-1, ISSN: 1476-5551.
Savani M, Oluwole O, Dholaria B. New targets for CAR T therapy in hematologic malignancies. Best Pract Res Clin Haematol [print-electronic]. 2021 Sep; 34(3): 101277. PMID: 34625226, PII: S1521-6926(21)00042-6, DOI: 10.1016/j.beha.2021.101277, ISSN: 1532-1924.
Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Aug; 27(8): 642-9. PMID: 34304802, PII: S2666-6367(21)00831-9, DOI: 10.1016/j.jtct.2021.04.007.
Geethakumari PR, Ramasamy DP, Dholaria B, Berdeja J, Kansagra A. Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments. Curr Hematol Malig Rep [print-electronic]. 2021 Aug; 16(4): 345-56. PMID: 34089485, PMCID: PMC8179081, PII: 10.1007/s11899-021-00635-3, DOI: 10.1007/s11899-021-00635-3, ISSN: 1558-822X.
Scordo M, Wang TP, Ahn KW, Chen Y, Ahmed S, Awan FT, Beitinjaneh A, Chen A, Chow VA, Dholaria B, Epperla N, Farooq U, Ghosh N, Grover N, Hamad N, Hildebrandt GC, Holmberg L, Hong S, Inwards DJ, Jimenez-Jimenez A, Karmali R, Kenkre VP, Khimani F, Klyuchnikov E, Krem MM, Munshi PN, Nieto Y, Prestidge T, Ramakrishnan Geethakumari P, Rezvani AR, Riedell PA, Seo S, Shah NN, Solh M, Yared JA, Kharfan-Dabaja MA, Herrera A, Hamadani M, Sauter CS. Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant. JAMA Oncol. 2021 Jul 7/1/2021; 7(7): 993-1003. PMID: 33956047, PMCID: PMC8283558, PII: 2779525, DOI: 10.1001/jamaoncol.2021.1074, ISSN: 2374-2445.
Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D. Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia [print-electronic]. 2021 Jul; 35(7): 2076-85. PMID: 33785862, PMCID: PMC8257494, PII: 10.1038/s41375-021-01213-5, DOI: 10.1038/s41375-021-01213-5, ISSN: 1476-5551.
Dholaria B, Savani BN, Huang XJ, Nagler A, Perales MA, Mohty M. The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy. Br J Haematol [print-electronic]. 2021 Jun; 193(6): 1060-75. PMID: 33928630, DOI: 10.1111/bjh.17460, ISSN: 1365-2141.
Dholaria B, Labopin M, Sanz J, Ruggeri A, Cornelissen J, Labussière-Wallet H, Blaise D, Forcade E, Chevallier P, Grassi A, Zubarovskaya L, Kuball J, Ceballos P, Ciceri F, Baron F, Savani BN, Nagler A, Mohty M. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia. J Hematol Oncol. 2021 May 5/3/2021; 14(1): 76. PMID: 33941226, PMCID: PMC8094558, PII: 10.1186/s13045-021-01086-2, DOI: 10.1186/s13045-021-01086-2, ISSN: 1756-8722.
Logue JM, Zucchetti E, Bachmeier CA, Krivenko GS, Larson V, Ninh D, Grillo G, Cao B, Kim J, Chavez JC, Baluch A, Khimani F, Lazaryan A, Nishihori T, Liu HD, Pinilla-Ibarz J, Shah BD, Faramand R, Coghill AE, Davila ML, Dholaria BR, Jain MD, Locke FL. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2021 Apr 4/1/2021; 106(4): 978-86. PMID: 32327504, PMCID: PMC8017820, PII: haematol.2019.238634, DOI: 10.3324/haematol.2019.238634, ISSN: 1592-8721.
Dholaria B, Labopin M, Angelucci E, Tischer J, Arat M, Ciceri F, Gülbas Z, Ozdogu H, Sica S, Diez-Martin JL, Koc Y, Pavlu J, Socié G, Giebel S, Savani BN, Nagler A, Mohty M. Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. Transplant Cell Ther [print-electronic]. 2021 Feb; 27(2): 171.e1-171.e8. PMID: 33830029, PII: S2666-6367(20)30017-8, DOI: 10.1016/j.jtct.2020.10.008, ISSN: 2666-6367.
Nagler A, Labopin M, Dholaria B, Angelucci E, Afanasyev B, Cornelissen JJ, Sica S, Meijer E, Ciceri F, Van Gorkom G, Kröger N, Martin H, Pioltelli P, Risitano A, Canaani J, Savani BN, Sanz J, Mohty M. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clin Cancer Res [print-electronic]. 2021 Feb 2/1/2021; 27(3): 843-51. PMID: 33148668, PII: 1078-0432.CCR-20-2809, DOI: 10.1158/1078-0432.CCR-20-2809, ISSN: 1557-3265.
Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, Ciurea SO, Holtzman NG, Ii GLP, Devine SM, Mannis G, Grunwald MR, Appelbaum F, Rodriguez C, El Chaer F, Shah N, Hashmi SK, Kharfan-Dabaja MA, DeFilipp Z, Aljurf M, AlShaibani A, Inamoto Y, Jain T, Majhail N, Perales MA, Mohty M, Hamadani M, Carpenter PA, Nagler A. Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. Transplant Cell Ther [print-electronic]. 2021 Jan; 27(1): 6-20. PMID: 32966881, PII: S1083-8791(20)30584-X, DOI: 10.1016/j.bbmt.2020.09.020.
Nagler A, Dholaria B, Labopin M, Bruno B, Rambaldi A, Pioltelli P, La Nasa G, Socié G, Mielke S, Ruggeri M, Saccardi R, Franke GN, Finke J, Savani BN, Ruggeri A, Mohty M. The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. Bone Marrow Transplant [print-electronic]. 2021 Jan; 56(1): 20-9. PMID: 32561816, PII: 10.1038/s41409-020-0974-6, DOI: 10.1038/s41409-020-0974-6, ISSN: 1476-5365.
Gorsline CA, Staub MB, Nelson GE, Nesbitt WJ, Dholaria BR, Satyanarayana G. Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers. Antimicrob Steward Healthc Epidemiol. 2021; 1(1): e22. PMID: 36168451, PMCID: PMC9495534, PII: S2732494X21001856, DOI: 10.1017/ash.2021.185, ISSN: 2732-494X.
Mangan BL, Patel D, Chen H, Gatwood KS, Byrne MT, Sengsayadeth S, Goodman S, Dholaria B, Kassim AA, Jagasia M, Chinratanalab W, Culos KA, Engelhardt BG. New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide. EJHaem [print-electronic]. 2020 Nov; 1(2): 576-80. PMID: 33709085, PMCID: PMC7942195, DOI: 10.1002/jha2.70, ISSN: 2688-6146.
Bar M, Ott SM, Lewiecki EM, Sarafoglou K, Wu JY, Thompson MJ, Vaux JJ, Dean DR, Saag KG, Hashmi SK, Inamoto Y, Dholaria BR, Kharfan-Dabaja MA, Nagler A, Rodriguez C, Hamilton BK, Shah N, Flowers MED, Savani BN, Carpenter PA. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant [print-electronic]. 2020 Oct; 26(10): 1784-802. PMID: 32653624, PII: S1083-8791(20)30410-9, DOI: 10.1016/j.bbmt.2020.07.001.
Patel A, Mobley BC, Jagasia M, Adetola K, Byrne M, Dholaria B. Pituitary Apoplexy During Hematopoietic Cell Transplantation. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Oct; 20(10): e691-e693. PMID: 32620383, PII: S2152-2650(20)30261-5, DOI: 10.1016/j.clml.2020.05.015, ISSN: 2152-2669.
Nagler A, Dholaria B, Labopin M, Savani BN, Angelucci E, Koc Y, Arat M, Pioltelli P, Sica S, Gülbas Z, Tischer J, Bernasconi P, Pavlu J, Socié G, Blaise D, Rigacci L, Martino M, Diez-Martin JL, Peric Z, Giebel S, Mohty M. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia [print-electronic]. 2020 Oct; 34(10): 2766-75. PMID: 32393841, PII: 10.1038/s41375-020-0850-9, DOI: 10.1038/s41375-020-0850-9, ISSN: 1476-5551.
Byrne M, Danielson N, Sengsayadeth S, Rasche A, Culos K, Gatwood K, Wyatt H, Chinratanalab W, Dholaria B, Ferrell PB, Fogo K, Goodman S, Jagasia M, Jayani R, Kassim A, Mohan SR, Savani BN, Strickland SA, Engelhardt BG, Savona M. The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. Am J Hematol [print-electronic]. 2020 Sep; 95(9): 1006-14. PMID: 32390196, DOI: 10.1002/ajh.25859, ISSN: 1096-8652.
Dholaria B, Vanegas YAM, Diehl N, Spaulding AC, Visscher S, Tun HW, Ailawadhi S, Vishnu P. Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features. Clin Hematol Int. 2020 Sep; 2(3): 117-24. PMID: 34595452, PMCID: PMC8432333, PII: CHI-2-3-117, DOI: 10.2991/chi.d.200410.001, ISSN: 2590-0048.
Dholaria B, Labopin M, Angelucci E, Ciceri F, Diez-Martin JL, Bruno B, Sica S, Koc Y, Gülbas Z, Schmid C, Blaise D, Carella AM, Visani G, Savani BN, Nagler A, Mohty M. Impact of total body irradiation- vs chemotherapy-based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia. Am J Hematol [print-electronic]. 2020 Jul 7/13/2020; PMID: 32656791, DOI: 10.1002/ajh.25934, ISSN: 1096-8652.
Dholaria B, Malki MMA, Artz A, Savani BN. Securing the graft during pandemic: are we ready for cryopreservation for all?. Biol Blood Marrow Transplant [print-electronic]. 2020 Jul; 26(7): e145-e146. PMID: 32305358, PMCID: PMC7162777, PII: S1083-8791(20)30219-6, DOI: 10.1016/j.bbmt.2020.04.009, ISSN: 1523-6536.
Bachanova V, Bishop MR, Dahi P, Dholaria B, Grupp SA, Hayes-Lattin B, Janakiram M, Maziarz RT, McGuirk JP, Nastoupil LJ, Oluwole OO, Perales MA, Porter DL, Riedell PA, . Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant [print-electronic]. 2020 Jul; 26(7): 1239-46. PMID: 32298807, PMCID: PMC7194685, PII: S1083-8791(20)30217-2, DOI: 10.1016/j.bbmt.2020.04.008, ISSN: 1523-6536.
Dholaria B, Savani BN. How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?. Br J Haematol [print-electronic]. 2020 Apr; 189(2): 239-40. PMID: 32180224, PMCID: PMC7161755, DOI: 10.1111/bjh.16597, ISSN: 1365-2141.
Moreno Vanegas YA, Juskevicius R, Dholaria B. Hepatitis C Virus-associated Lymphoplasmacytic Lymphoma With Waldenström Macroglobulinemia: Response to Direct-acting Antiviral Therapy. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Apr; 20(4): e195-e199. PMID: 32033929, PII: S2152-2650(20)30040-9, DOI: 10.1016/j.clml.2020.01.004, ISSN: 2152-2669.
Nagler A, Dholaria B, Labopin M, Socie G, Huynh A, Itälä-Remes M, Deconinck E, Yakoub-Agha I, Cahn JY, Bourhis JH, Labussière-Wallet H, Chantepie S, Esteve J, Savani B, Mohty M. The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation. Leukemia [print-electronic]. 2019 Nov 11/14/2019; PMID: 31728052, PII: 10.1038/s41375-019-0631-5, DOI: 10.1038/s41375-019-0631-5, ISSN: 1476-5551.
Dholaria B, Savani BN. Allogeneic haematopoietic cell transplantation after CAR T-cell therapy: safe, effective and contentious [editorial]. Br. J. Haematol [print-electronic]. 2019 Nov 11/8/2019; PMID: 31702832, DOI: 10.1111/bjh.16262, ISSN: 1365-2141.
Hammond WA, Vishnu P, Rodriguez EM, Li Z, Dholaria B, Shreders AJ, Rivera CE. Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?. Mayo Clin. Proc. 2019 Nov; 94(11): 2199-208. PMID: 31685150, PII: S0025-6196(19)30506-3, DOI: 10.1016/j.mayocp.2019.05.024, ISSN: 1942-5546.
Dholaria B, Savani BN, Labopin M, Luznik L, Ruggeri A, Mielke S, Al Malki MM, Kongtim P, Fuchs E, Huang XJ, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Solomon S, Romee R, Lewalle P, Gayoso J, Maschan M, Lazarus HM, Ballen K, Giebel S, Baron F, Ciceri F, Esteve J, Gorin NC, Spyridonidis A, Schmid C, Ciurea SO, Nagler A, Mohty M. Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT. Haematologica [print-electronic]. 2019 Sep 9/19/2019; PMID: 31537691, PII: haematol.2019.219790, DOI: 10.3324/haematol.2019.219790, ISSN: 1592-8721.
Nagler A, Labopin M, Dholaria B, Niittyvuopio R, Maertens J, Poiré X, Cornelissen J, Reményi P, Bourhis JH, Beguin Y, Malladi R, Kerre T, Schroyens W, Savani BN, Mohty M. Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Adv. 2019 Jul 7/9/2019; 3(13): 1950-60. PMID: 31262738, PMCID: PMC6616257, PII: bloodadvances.2019000030, DOI: 10.1182/bloodadvances.2019000030, ISSN: 2473-9537.
Soyano AE, Dholaria B, Marin-Acevedo JA, Diehl N, Hodge D, Luo Y, Manochakian R, Chumsri S, Adjei A, Knutson KL, Lou Y. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies. J Immunother Cancer. 2018 Nov 11/23/2018; 6(1): 129. PMID: 30470260, PMCID: PMC6251165, PII: 10.1186/s40425-018-0447-2, DOI: 10.1186/s40425-018-0447-2, ISSN: 2051-1426.
Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S. Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med [print-electronic]. 2018 Oct; 7(10): 4932-42. PMID: 30175515, PMCID: PMC6198232, DOI: 10.1002/cam4.1749, ISSN: 2045-7634.
Ailawadhi S, Dholaria BR, Khurana S, Sher T, Alegria V, Paulus A, Ailawadhi M, Mehta A, Chanan-Khan A, Roy V. Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma [letter]. Br. J. Haematol [print-electronic]. 2018 Jul 7/5/2018; PMID: 29978498, DOI: 10.1111/bjh.15458, ISSN: 1365-2141.
Dholaria BR, Ayala E, Sokol L, Nishihori T, Chavez JC, Hussaini M, Kumar A, Kharfan-Dabaja MA. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience. Leuk. Res [print-electronic]. 2018 Apr; 67: 1-5. PMID: 29407180, PII: S0145-2126(18)30015-8, DOI: 10.1016/j.leukres.2018.01.009, ISSN: 1873-5835.
Dholaria BR, Hammond WA, Roy V, Sher T, Vishnu P, Soyano A, Finn LE, Tun H. Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience. Leuk. Lymphoma [print-electronic]. 2018 Mar 3/23/2018; 1-4. PMID: 29566563, DOI: 10.1080/10428194.2018.1452220, ISSN: 1029-2403.
Marin-Acevedo JA, Dholaria B, Soyano AE, Knutson KL, Chumsri S, Lou Y. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 3/15/2018; 11(1): 39. PMID: 29544515, PMCID: PMC5856308, PII: 10.1186/s13045-018-0582-8, DOI: 10.1186/s13045-018-0582-8, ISSN: 1756-8722.
Marin-Acevedo JA, Soyano AE, Dholaria B, Knutson KL, Lou Y. Cancer immunotherapy beyond immune checkpoint inhibitors. J Hematol Oncol. 2018 Jan 1/12/2018; 11(1): 8. PMID: 29329556, PMCID: PMC5767051, PII: 10.1186/s13045-017-0552-6, DOI: 10.1186/s13045-017-0552-6, ISSN: 1756-8722.
Dholaria B, Patel RJ, Sluzevich JC, Ailawadhi S, Roy V. Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant. Ann. Hematol [print-electronic]. 2017 Dec; 96(12): 2125-6. PMID: 28879427, PII: 10.1007/s00277-017-3119-2, DOI: 10.1007/s00277-017-3119-2, ISSN: 1432-0584.
Dholaria B, Hammond W, Shreders A, Lou Y. Emerging therapeutic agents for lung cancer. J Hematol Oncol. 2016 Dec 12/9/2016; 9(1): 138. PMID: 27938382, PMCID: PMC5148871, PII: 10.1186/s13045-016-0365-z, DOI: 10.1186/s13045-016-0365-z, ISSN: 1756-8722.
Dholaria B, Bhasin A, Krishna M, Finn L. Adoptive transfer of food allergy via unrelated allogeneic bone marrow transplant. Ann. Allergy Asthma Immunol [print-electronic]. 2016 Jul; 117(1): 96-7. PMID: 27236219, PII: S1081-1206(16)30184-3, DOI: 10.1016/j.anai.2016.04.026, ISSN: 1534-4436.
Dholaria BR, Cappel M, Roy V. Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone. Ann. Hematol [print-electronic]. 2016 Mar; 95(4): 671-2. PMID: 26814914, PII: 10.1007/s00277-016-2604-3, DOI: 10.1007/s00277-016-2604-3, ISSN: 1432-0584.
Dholaria B, Srinivasan S. T-DM1-related carotenoderma and hand-foot syndrome. Lancet. 2015 Apr 4/18/2015; 385(9977): 1509-10. PMID: 25933279, PII: S0140-6736(15)60752-8, DOI: 10.1016/S0140-6736(15)60752-8, ISSN: 1474-547X.
Dholaria BR, Pant S, Lavender RC, Agarwal A. The great imitator: psychosis that responded to penicillin. Can Fam Physician. 2014 Sep; 60(9): 818-21. PMID: 25217678, PMCID: PMC4162698, PII: 60/9/818, ISSN: 1715-5258.
Dholaria B, Alapat D, Arnaoutakis K. Primary bone marrow Hodgkin lymphoma in an HIV-negative patient. Int. J. Hematol [print-electronic]. 2014 Apr; 99(4): 503-7. PMID: 24532438, DOI: 10.1007/s12185-014-1532-z, ISSN: 1865-3774.
Dholaria B, Alapat D, Pandey T, Agarwal A. Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat. Med. Oncol [print-electronic]. 2012 Dec; 29(5): 3529-34. PMID: 22562157, DOI: 10.1007/s12032-012-0248-2, ISSN: 1559-131X.
Pant S, Deshmukh A, Dholaria B, Kaur V, Ramavaram S, Ukor M, Teran GA. Spicy seizure. Am. J. Med. Sci. 2012 Jul; 344(1): 67-8. PMID: 22627260, PII: S0002-9629(15)30924-1, DOI: 10.1097/MAJ.0b013e31824cf5c2, ISSN: 1538-2990.